Proshares Trust (ZBIO) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $13.8 million.
- Zenas BioPharma's Other Non-Current Assets rose 5301.55% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 5301.55%. This contributed to the annual value of $12.9 million for FY2024, which is 7669.05% up from last year.
- Per Zenas BioPharma's latest filing, its Other Non-Current Assets stood at $13.8 million for Q3 2025, which was up 5301.55% from $11.8 million recorded in Q2 2025.
- Zenas BioPharma's Other Non-Current Assets' 5-year high stood at $13.8 million during Q3 2025, with a 5-year trough of $86000.0 in Q3 2023.
- For the 3-year period, Zenas BioPharma's Other Non-Current Assets averaged around $9.7 million, with its median value being $11.8 million (2025).
- As far as peak fluctuations go, Zenas BioPharma's Other Non-Current Assets soared by 1038837.21% in 2024, and later soared by 5301.55% in 2025.
- Over the past 3 years, Zenas BioPharma's Other Non-Current Assets (Quarter) stood at $7.3 million in 2023, then surged by 76.69% to $12.9 million in 2024, then increased by 7.36% to $13.8 million in 2025.
- Its Other Non-Current Assets stands at $13.8 million for Q3 2025, versus $11.8 million for Q2 2025 and $12.8 million for Q1 2025.